Pharmaceutical membrane separation system for veterinary drugs and Chinese patent medicines

How Membrane Technology Outperforms Traditional Thermal Methods

Traditional processing of Chinese herbal extracts often relies on high-temperature evaporation, which degrades heat‑sensitive active compounds, consumes substantial energy, and generates large volumes of wastewater. To overcome these limitations, BluewavBio has developed an advanced pharmaceutical membrane separation system that integrates clarification and low‑temperature concentration, tailored specifically for veterinary drugs and Chinese patent medicines.

Process Overview

The membrane‑based workflow typically includes:

• Pre‑filtration – removes coarse particles and protects downstream membranes.
• Membrane clarification (microfiltration/ultrafiltration) – eliminates suspended solids, colloids, and macromolecules while preserving active small‑molecule ingredients.
• Membrane concentration (nanofiltration/reverse osmosis) – concentrates the clarified extract at controlled low temperatures without phase change, achieving the desired density while retaining thermosensitive components.
• Optional final drying – the membrane‑concentrated liquid can be further dried into granules, tablets, or powders for solid dosage forms.

Key Advantages

• Up to 80% energy reduction compared to conventional thermal concentration.
• Superior product clarity, stability, and bioavailability of active compounds.
• Gentle, low‑temperature operation protects heat‑sensitive ingredients.
• Scalable, modular design suitable for pilot to production scales.
• Reduced wastewater and environmental footprint, aligning with green manufacturing goals.

The membrane‑concentrated liquid can be formulated directly into oral liquids or further processed into solid preparations. This integrated approach not only elevates product quality but also significantly lowers production costs, enhancing the competitiveness of veterinary drugs and Chinese patent medicines.